Article
Structural basis for streptogramin B resistance in Staphylococcus aureus by virginiamycin B lyase
12 Jun 2007
Abstract excerpt
The streptogramin combination therapy of quinupristin-dalfopristin (Synercid) is used to treat infections caused by bacterial pathogens, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. However, the effectiveness of this therapy is being compromised because of an increased incidence of streptogramin resistance. One of the clinically observed mechanisms of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
